Chronic hyponatremia impairs memory in rats: Effects of vasopressin antagonist tolvaptan

Journal of Endocrinology

Volumn 206, Issue 1, 2010, Pages 105-111

  Miyazaki, Toshiki ^a   Ohmoto, Koji ^a   Hirose, Tsuyoshi ^a   Fujiki, Hiroyuki ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TOLVAPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPONATREMIA; MALE; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AVOIDANCE LEARNING; BENZAZEPINES; BODY WATER; BRAIN; DEAMINO ARGININE VASOPRESSIN; HYPONATREMIA; MALE; MEMORY; MEMORY DISORDERS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, VASOPRESSIN; SODIUM;

EID: 77953839299     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0050     Document Type: Article

References (29)

1. Anglade F, Chapouthier G & Galey D 1999 Intraseptal injection of scopolamine increases the effect of systemic diazepam on passive avoidance learning and emotionality in rats. Life Sciences 64 1553-1561.
2. Bedford JJ & Leader JP 1993 Response of tissues of the rat to anisosmolality in vivo. American Journal of Physiology 264 R1164-R1179.
3. Danysz W, Wroblewski JT & Costa E 1988 Learning impairment in rats by N-methyl-D-asparate receptor antagonists. Neuropharmacology 27 653-656.
4. Darbra S, Balada F, Martí-Carbonell MA & Garau A 2004 Perinatal hypothyroidism effects on step-through passive avoidance task in rats. Physiology and Behavior 82 497-501.
5. Doyle E & Regan CM 1993 Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM sialylation state. Journal of Neural Transmission 92 33-49.
6. Food and Drug Administration. FDA Labeling Information 2009 FDA web site [online], http://www.fda.gov/Drugs/default.htm.
7. Gandolfi O, Dall'Olio R, Roncada P & Montanaro N 1990 NMDA antagonists interact with 5-HT-stimulated phosphatidylinositol metabolism and impair passive avoidance retention in the rat. Neuroscience Letters 113 304-308.
8. Gard PR 2002 The role of angiotensin II in cognition and behaviour. European Journal of Pharmacology 438 1-14.
9. Hiramatsu M, Murasawa H, Nabeshima T & Kameyama T 1998 Effects of U-50, 488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats. Journal of Pharmacology and Experimental Therapeutics 284 858-867.
10. Hirano T, Yamamura Y, Nakamura S, Onogawa T & Mori T 2000 Effects of the V2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats. Journal of Pharmacology and Experimental Therapeutics 292 288-294. (Pubitemid 30026383)
11. Irwin S 1968 Comprehensive observational assessment: Ia. A systemic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13 222-257.
12. Lien YH, Shapiro JI & Chan L 1991 Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Journal of Clinical Investigation 88 303-309.
13. Massieu L, Montiel T, Robles G & Quesada O 2004 Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies. Neurochemical Research 29 73-81.
14. Miller M 2006 Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. Journal of the American Geriatrics Society 54 345-353.
15. Miyazaki T, Yamamura Y, Onogawa T, Nakamura S, Kinoshita S, Nakayama S, Fujiki H & Mori T 2005 Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia. Endocrinology 146 3037-3043.
16. Piercey MF, Vogelsang GD, Franklin SR & Tang AH 1987 Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces. Brain Research 272 1-9.
17. Renneboog B, Musch W, Vandemergel X, Manto MU & Decaux G 2006 Mild chronic hyponatremia is associated with fall, unsteadiness, and attention deficits. American Journal of Medicine 119 71.e1-71.e8.
18. Riekkinen M, Stefanski R, Kuitunen J & Riekkinen P Jr 1996 Effects of combined block of alpha 1-adrenoceptors and NMDA receptors on spatial and passive avoidance behavior in rats. European Journal of Pharmacology 300 9-16.
19. Sandhu HS, Gilles E, DeVita MV & Michelis MF 2009 Hyponatremia associated with large-bone fracture in elderly patients. International Urology and Nephrology 41 733-737.
20. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C & for the SALT Investigators 2006 Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. New England Journal of Medicine 355 2099-2112.
21. Song J, Hu X, Khan O, Tian Y, Verbalis JG & Ecelbarger CA 2004 Increased blood pressure, ardosterone activity, and regional differences in renal ENaC protein during vasopressin escape. American Journal of Physiology 287 F1076-F1083.
22. Soupart A & Decaux G 1996 Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clinical Nephrology 46 149-169. (Pubitemid 26306525)
23. Thurston JH & Hauhart RE 1987 Brain amino acids decrease in choronic hyponatremia and rapid correction causes brain dehydration: possible clinical significance. Life Sciences 40 2539-2542.
24. Venable N & Kelly PH 1990 Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology 100 215-221.
25. Verbalis JG & Gullans SR 1991 Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Research 567 274-282.
26. Verbalis JG, Zeltser D, Smith N, Barve A & Andoh M 2008 Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study. Clinical Endocrinology 69 159-168.
27. Waseem TV, Konev SV & Fedorovich SV 2004 Influence of hypotonic shock on glutamate and GABA uptake in rat brain synaptosomes. Neurochemical Research 29 1653-1658.
28. Yamamura Y, Nakamura S, Itoh S, Hirano T, Onogawa T, Yamashita T, Yamada Y, Tsujimae K, Aoyama M, Kotosai K et al. 1998 OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. Journal of Pharmacology and Experimental Therapeutics 287 860-867.
29. Yu HY, Liu MG, Liu DN, Shang GW, Wang Y, Qi C, Zhang KP, Song ZJ & Chen J 2007 Antinociceptive effects of paeoniflorin on bee venom-induced various 'phenotypes' of nociception and hypersensitivity. Pharmacology, Biochemistry, and Behavior 88 131-140.